Genetic and bioprocess engineering to improve squalene production in Yarrowia lipolytica
Loading...
Author/Creator
Author/Creator ORCID
Date
2020-08-10
Type of Work
Department
Program
Citation of Original Publication
Huan Liu, Fang Wang, Li Deng and Peng Xu, Genetic and bioprocess engineering to improve squalene production in Yarrowia lipolytica, Bioresource Technology Volume 317, 123991 (2020), https://doi.org/10.1016/j.biortech.2020.123991
Rights
This item is likely protected under Title 17 of the U.S. Copyright Law. Unless on a Creative Commons license, for uses protected by Copyright Law, contact the copyright holder or the author.
Attribution 4.0 International
Attribution 4.0 International
Subjects
Abstract
Squalene is the precursor for triterpene-based natural products and steroids-based drugs. It has been widely used as pharmaceutical intermediates and personal care products. The aim of this work is to test the feasibility of engineering Yarrowia lipolytica as a potential host for squalene production. The bottleneck of the pathway was removed by overexpressing native HMG-CoA (3-hydroxy-3-methylglutaryl-CoA) reductase. With the recycling of NADPH from the mannitol cycle, the engineered strain produced about 180.3 mg/L and 188.2 mg/L squalene from glucose or acetate minimal media. By optimizing the C/N ratio, controlling the media pH and mitigating acetyl-CoA flux competition from lipogenesis, the engineered strain produced 502.7 mg/L squalene, a 28-fold increase over the parental strain (17.2 mg/L). This work may serve as a baseline to harness Y. lipolytica as an oleaginous cell factory for sustainable production of squalene or terpenoids-based chemicals and natural products.